These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26624958)

  • 1. ADDENDUM.
    Am J Psychiatry; 2015 Dec; 172(12):1256. PubMed ID: 26624958
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjunctive Ziprasidone in Major Depression and the Current Status of Adjunctive Atypical Antipsychotics.
    Nelson JC
    Am J Psychiatry; 2015 Dec; 172(12):1176-8. PubMed ID: 26619770
    [No Abstract]   [Full Text] [Related]  

  • 3. Antidepressant effects of nortriptyline and escitalopram in the GENDEP study: is one better than the other?
    Uher R; Mors O; McGuffin P
    Acta Psychiatr Scand; 2013 Apr; 127(4):330. PubMed ID: 23480387
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here?
    McMahon FJ
    Am J Psychiatry; 2015 Aug; 172(8):697-9. PubMed ID: 26234589
    [No Abstract]   [Full Text] [Related]  

  • 5. Intranasal oxytocin as an adjunct to escitalopram in major depression.
    Scantamburlo G; Ansseau M; Geenen V; Legros JJ
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E5. PubMed ID: 21677229
    [No Abstract]   [Full Text] [Related]  

  • 6. Escitalopram versus nortriptyline: how to let the clinical GENDEP data tell us what they contained.
    Bech P; Allerup P; Larsen ER; Csillag C; Licht RW
    Acta Psychiatr Scand; 2013 Apr; 127(4):328-9. PubMed ID: 23480386
    [No Abstract]   [Full Text] [Related]  

  • 7. Levomilnacipran and Vortioxetine for Adults with Major Depressive Disorder.
    Scarff JR
    J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):131-3. PubMed ID: 27141705
    [No Abstract]   [Full Text] [Related]  

  • 8. Vilazodone, levomilnacipran and vortioxetine for major depressive disorder: the 15-min challenge to sort these agents out.
    Citrome L
    Int J Clin Pract; 2015 Feb; 69(2):151-5. PubMed ID: 25627335
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of vilazodone 20 and 40 mg in major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Mathews M; Gommoll C; Chen D; Nunez R; Khan A
    Int Clin Psychopharmacol; 2015 Mar; 30(2):67-74. PubMed ID: 25500685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vilazodone (viibryd) for the treatment of depression.
    Gazewood JD; Slayton P; Degeorge K
    Am Fam Physician; 2013 Aug; 88(4):263-4. PubMed ID: 23944730
    [No Abstract]   [Full Text] [Related]  

  • 11. Vilazodone's comparative merits yet to be demonstrated.
    Dopheide JA
    Am J Health Syst Pharm; 2012 Sep; 69(18):1549. PubMed ID: 22935936
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on "Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials".
    Pae CU
    Gen Hosp Psychiatry; 2010; 32(4):448; author reply 449. PubMed ID: 20633759
    [No Abstract]   [Full Text] [Related]  

  • 13. Aripiprazole in refractory depression?
    Carroll BJ
    J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary evidence that early reduction in p11 levels in natural killer cells and monocytes predicts the likelihood of antidepressant response to chronic citalopram.
    Svenningsson P; Berg L; Matthews D; Ionescu DF; Richards EM; Niciu MJ; Malinger A; Toups M; Manji H; Trivedi MH; Zarate CA; Greengard P
    Mol Psychiatry; 2014 Sep; 19(9):962-4. PubMed ID: 24614495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
    Tsai AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylphenidate augmentation of citalopram in elderly depressed patients.
    Lavretsky H; Kumar A
    Am J Geriatr Psychiatry; 2001; 9(3):298-303. PubMed ID: 11481139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant effects of citalopram on treatment of alopecia areata in patients with major depressive disorder.
    Abedini H; Farshi S; Mirabzadeh A; Keshavarz S
    J Dermatolog Treat; 2014 Apr; 25(2):153-5. PubMed ID: 23339335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole as an adjunctive treatment for refractory major depression.
    Hellerstein DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1347-8. PubMed ID: 15588762
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole adjunctive to antidepressant therapy.
    Marcus RM; Sanchez R; Frost M; McQuade RD
    Am J Psychiatry; 2011 Feb; 168(2):211; author reply 211. PubMed ID: 21297051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.